Company Insight – Page 13 – media

Alta Partners Raise $130 Million Venture Capital for Biotech Development

San Francisco based Healthcare venture capital firm Alta Partners has launched funds titled as Alta Partner NextGen Fund I. The new fund will focus on the new development of therapeutics and health technology services. This will be the 9th fund in Alta Partners firms History.
- Source: FierceBiotech
- 617
- June 14, 2018
Company Insight healthcare technologies and innovations
Anti-Aging Stratup Juvenescence Raises $50 Million for New Project

The Isle of Man-based anti-aging biotech company is focusing on developing therapeutics for human longevity by partnering, creating, and investing in companies with anti-aging related projects.
- Source: Fierce Biotech
- 478
- June 13, 2018
biotech Company Insight funding
AbbvVie Under Fire From FDA Over Humira’s Death Complaints

Last year the FDA inspected the AbbVie North Chicago manufacturing site during which time they discovered that the company failed to do a proper investigation on five death complaints received relating to Humira and Venclexta treatments. Though the drug maker reported the deaths, it didn’t collate the historical data of the lots in question. It was later discovered that the lots were tied to another 8 to 10 deaths.
- Source: Fierce Pharma
- 616
- June 12, 2018
AbbVie Company Insight pharma
Sensome Raised $5.4 Million to Outfit Ischemic Stroke Treatment

Sensome’s latest developed Clotild is focused on treating ischemic strokes. The company stated that even though there are numerous methods available for the treatment of the blocked brain arteries, it is difficult to ensure the right treatment or to control it, without identifying the composition of the clot first.
- Source: MobiHealthNews
- 638
- June 12, 2018
Company Insight medtech stroke
Emergent BioSolutions to Invest $50M for Expansion

Emergent BioSolutions, Gaithersburg, Maryland-based Biopharmaceutical Company announced that it will invest $50 million for the next three years to expand the manufacturing capacity for its Camden fill-finish in Baltimore facility. By the time the project has been completed in three years, it is expected to add up 60 jobs.
- Source: FiercePharma
- 781
- June 11, 2018
biopharmaceutical Company Insight
Wasdell Half-Million Investment For Lab Expansion

The UK Based, Wasdell Group a leading service provider for the pharma and medical industries, is planning to invest $671,000 to support its pharma manufacturing through a laboratory project; before the end of this year, the company is also planning to move into sterile manufacturing.
- Source: Fierce Pharma
- 1,096
- June 11, 2018
Company Insight pharmaceutical
FDA Seeks Help From Social Media Giants To Help Stop Illegal Opioid Distribution

Scott Gottlieb, FDA Commissioner is looking for help from Facebook and Twitter to slow down the unauthorized opioid sales in the US. Gottlieb invited the two social media giants, among others, to participate in the FDA Online Opioid Summit which is set for June 27.
- Source: Fierce Pharma
- 572
- June 11, 2018
Company Insight digital health FDA opioid
Johnson & Johnson Embroiled In Cancer Trial

It has been stated by the women and their families taking legal actions mentioned that the cancer was caused by decade-long use of J&J’s Baby Powder and other cosmetic. The petitioners have alleged that the company failed to warn consumers about cancer risks in spite of the knowledge that its talc was contaminated with asbestos at least since the 1970s.
- Source: CNBC
- 663
- June 8, 2018
Company Insight Johnson & Johnson lawsuit
iBeat Raises Investment for its Continuous Monitor mHealth Wearable; Heart Watch

San Francisco-based company iBeat, an mHealth wearable development company has announced new funding from form SCOR Life & Transamerica Ventures and Health Ventures for its mHealth devices, Heart Watch which continuously monitors the heart.. iBeat did not state what the total amount was, only that the investments round was “upward of seven figures”.
- Source: MobiHealthNews
- 972
- June 8, 2018
Company Insight mHealth wearables
FDA Recalls HeartMate device Manufactured by Abbott

This will be the second recall on a heart device this month Medtronic’s Heartware device and accessories was recalled a few days ago. This comes after Abbott issued a patch to negate cybersecurity issues 350,000 remote monitoring systems and pacemakers.
- Source: Ddu
- 709
- June 7, 2018
Abbott Company Insight heart failure medical device

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.